Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality.
Masson S, Marchioli R, Mozaffarian D, Bernasconi R, Milani V, Dragani L, Tacconi M, Marfisi RM, Borgese L, Cirrincione V, Febo O, Nicolis E, Maggioni AP, Tognoni G, Tavazzi L, Latini R. Masson S, et al. Among authors: marfisi rm. Am Heart J. 2013 Feb;165(2):208-15.e4. doi: 10.1016/j.ahj.2012.10.021. Epub 2013 Jan 4. Am Heart J. 2013. PMID: 23351824 Clinical Trial.
Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
Macchia A, Levantesi G, Franzosi MG, Geraci E, Maggioni AP, Marfisi R, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione Investigators. Macchia A, et al. Eur J Heart Fail. 2005 Aug;7(5):904-9. doi: 10.1016/j.ejheart.2005.04.008. Eur J Heart Fail. 2005. PMID: 16087142 Free article.
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F; GISSI-Prevenzione Investigators. Marchioli R, et al. Among authors: marfisi rm. Circulation. 2002 Apr 23;105(16):1897-903. doi: 10.1161/01.cir.0000014682.14181.f2. Circulation. 2002. PMID: 11997274 Clinical Trial.
Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
Marchioli R, Marfisi RM, Borrelli G, Chieffo C, Franzosi MG, Levantesi G, Maggioni AP, Nicolosi GL, Scarano M, Silletta MG, Schweiger C, Tavazzi L, Tognoni G. Marchioli R, et al. Among authors: marfisi rm. J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S34-7. doi: 10.2459/01.JCM.0000289271.80180.b6. J Cardiovasc Med (Hagerstown). 2007. PMID: 17876196
Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction.
Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Silletta MG, Tavazzi L, Tognoni G, Marchioli R. Levantesi G, et al. Among authors: marfisi rm. Int J Cardiol. 2013 Jul 15;167(1):262-9. doi: 10.1016/j.ijcard.2011.12.110. Epub 2012 Jan 20. Int J Cardiol. 2013. PMID: 22261690 Clinical Trial.
Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.
Franzosi MG, Brunetti M, Marchioli R, Marfisi RM, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators. Franzosi MG, et al. Among authors: marfisi rm. Pharmacoeconomics. 2001;19(4):411-20. doi: 10.2165/00019053-200119040-00008. Pharmacoeconomics. 2001. PMID: 11383757
54 results